CGRP antagonists in the acute treatment of migraine.
Lipton
Richard B
RB
Department of Neurology, Epidemiology and Population Health, Albert Einstein College of Medicine, New York, NY, USA. rlipton@aecom.yu.edu
Dodick
David W
DW
D000208:Acute Disease; D015740:Calcitonin Gene-Related Peptide / Q000037:antagonists & inhibitors* / Q000378:metabolism; D002536:Cerebral Arteries / Q000187:drug effects / Q000294:innervation / Q000503:physiopathology; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D010879:Piperazines / Q000494:pharmacology* / Q000627:therapeutic use; D011799:Quinazolines / Q000494:pharmacology* / Q000627:therapeutic use; D014276:Trigeminal Nerve / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology; D014661:Vasoconstriction / Q000187:drug effects / Q000502:physiology; D014662:Vasoconstrictor Agents / Q000009:adverse effects
D010879:Piperazines; D011799:Quinazolines; D014662:Vasoconstrictor Agents; D015740:Calcitonin Gene-Related Peptide; C406305:olcegepant